Streck, Inc. and Dow Biomedica, a Korean distributor of diagnostic products specializing in immunology, microbiology and QC materials, have signed a distribution agreement for Streck’s cell stabilization, molecular and flow cytometry products.
Streck’s cell stabilization products include Cell-Free DNA BCT® CE, a direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA for a wide range of downstream applications commonly used in clinical research studies, drug discovery and diagnostic assay development; and Cell-Free RNA BCT® CE, a blood collection tube with a patented preservative which stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage. The tubes are for Export Only. Not for sale in the U.S.
Streck’s Molecular Products division is focused on the generation of rapid diagnostic tools that impact healthcare decisions. Streck’s molecular product line includes the ARM-D® Kits for the detection of antibiotic resistance genes by multiplex real-time PCR and the soon-to-launch rapid real-time PCR instrument, the Zulu RT™, capable of 40 cycle reactions in 20 minutes or less. In addition, Streck is developing a library of diagnostics tools that will soon be available in Korea and the rest of the world.
“Dow Biomedica continuously pursues improving service for our customers, and our partnership with Streck will enable us to provide customers with the premium quality cell stabilization and flow cytometry products they need for their downstream applications,” said YG Shin, President and CEO of Dow Biomedica.
“We are pleased to partner with a company that will allow Streck increased market penetration,” said Connie Ryan, President and CEO at Streck. “In addition, Dow Biomedica will be able to provide excellent local support to our Korean customers.”
About Dow Biomedica
Established in 2004, Dow Biomedica has been growing to become one of the leading quality providers in the dynamically changing market environment of Korea. Its mission is to provide state-of-the-art
information and support to its customers.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.